Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

Overview of attention for article published in BMC Cancer, May 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,108 followers.

Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 an... http://t.co/Wc7plx9swI

Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and… http://t.co/WiyaNoIVUW

Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/... http://t.co/flXN399QBh #cancer

◈ Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CS... http://t.co/6LnC0S8MUE ◈

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.